Well, I am sure you just re-counted the number of symptoms in my list and concluded that there were only 49
MGF (Mechano Growth Factor): MGF is specifically a splice variant of IGF-1 targeting skeletal muscle
Gao 2023 (human GLP1R-variant series) puts a number on it at the GLP-1 receptor: cAMP output saturates at roughly 10% (103%) receptor surface expression, so full effect sits far below full occupancy
System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma
N-Acetylaspartate reductions in brain injury: Impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation
This comes shortly after the Company's news release dated July 14, 2026 highlighting that the Company received a 20,000-unit production run of its BPC-157 transdermal patch